KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Liabilities and Shareholders Equity (2016 - 2026)

Lam Research has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $20.8 billion for Q1 2026.

  • For Q1 2026, Liabilities and Shareholders Equity rose 4.12% year-over-year to $20.8 billion; the TTM value through Mar 2026 reached $85.4 billion, up 9.4%, while the annual FY2025 figure was $21.3 billion, 13.87% up from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 was $20.8 billion at Lam Research, down from $21.4 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $21.9 billion in Q3 2025 and troughed at $16.6 billion in Q1 2022.
  • A 5-year average of $19.3 billion and a median of $19.2 billion in 2022 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: increased 20.27% in 2022 and later dropped 5.01% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $19.2 billion in 2022, then fell by 2.2% to $18.8 billion in 2023, then increased by 5.62% to $19.8 billion in 2024, then grew by 7.82% to $21.4 billion in 2025, then dropped by 2.8% to $20.8 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for LRCX at $20.8 billion in Q1 2026, $21.4 billion in Q4 2025, and $21.9 billion in Q3 2025.